362 related articles for article (PubMed ID: 15596304)
1. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
[TBL] [Abstract][Full Text] [Related]
2. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
[TBL] [Abstract][Full Text] [Related]
3. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
[TBL] [Abstract][Full Text] [Related]
4. [Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port].
Crisinel M; Mahy S; Ortega-Debalon P; Buisson M; Favre JP; Chavanet P; Piroth L
Med Mal Infect; 2009 Apr; 39(4):252-8. PubMed ID: 19108966
[TBL] [Abstract][Full Text] [Related]
5. Late complications associated with totally implantable venous access port implantation via the internal jugular vein.
Tsuruta S; Goto Y; Miyake H; Nagai H; Yoshioka Y; Yuasa N; Takamizawa J
Support Care Cancer; 2020 Jun; 28(6):2761-2768. PubMed ID: 31724073
[TBL] [Abstract][Full Text] [Related]
6. Comparison of methods for the microbiological diagnosis of totally implantable venous access port-related infections.
Kaya E; Tollapi L; Pastore A; Aringhieri G; Maisetta G; Barnini S; Paolicchi A; Batoni G; Esin S
J Med Microbiol; 2020 Nov; 69(11):1273-1284. PubMed ID: 33064069
[No Abstract] [Full Text] [Related]
7. Outcome of totally implantable venous-access port-related infections.
Vidal M; Genillon JP; Forestier E; Trouiller S; Pereira B; Mrozek N; Aumeran C; Lesens O
Med Mal Infect; 2016 Feb; 46(1):32-8. PubMed ID: 26778362
[TBL] [Abstract][Full Text] [Related]
8. Radiologic placement of a low profile implantable venous access port in a pediatric population.
Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.
Schwarz RE; Groeger JS; Coit DG
Cancer; 1997 Apr; 79(8):1635-40. PubMed ID: 9118051
[TBL] [Abstract][Full Text] [Related]
10. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients.
Bassi KK; Giri AK; Pattanayak M; Abraham SW; Pandey KK
Indian J Cancer; 2012; 49(1):114-8. PubMed ID: 22842178
[TBL] [Abstract][Full Text] [Related]
11. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.
Fernandez-Hidalgo N; Almirante B; Calleja R; Ruiz I; Planes AM; Rodriguez D; Pigrau C; Pahissa A
J Antimicrob Chemother; 2006 Jun; 57(6):1172-80. PubMed ID: 16597634
[TBL] [Abstract][Full Text] [Related]
13. Totally implantable femoral vein catheters in cancer patients.
Wolosker N; Yazbek G; Munia MA; Zerati AE; Langer M; Nishinari K
Eur J Surg Oncol; 2004 Sep; 30(7):771-5. PubMed ID: 15296992
[TBL] [Abstract][Full Text] [Related]
14. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients.
Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF
Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032
[TBL] [Abstract][Full Text] [Related]
15. Experience with the intravenous totally implanted port in patients with gynecologic malignancies.
Nelson BE; Mayer AR; Tseng PC; Schwartz PE
Gynecol Oncol; 1994 Apr; 53(1):98-102. PubMed ID: 8175028
[TBL] [Abstract][Full Text] [Related]
16. [Implantable catheter systems. Experiences with 1000 patients with central venous ports].
Kock HJ; Krause U; Pietsch M; Rasfeld S; Walz MK
Dtsch Med Wochenschr; 1996 Jan; 121(3):47-51. PubMed ID: 8565809
[TBL] [Abstract][Full Text] [Related]
17. [Central venous totally implantable access for high dose chemotherapy in children].
Conter C; Carausu L; Martin E; Rubie H; Castex MP; Marec-Berard P
Arch Pediatr; 2006 Mar; 13(3):256-61. PubMed ID: 16469486
[TBL] [Abstract][Full Text] [Related]
18. Multilumen central venous catheters increase risk for catheter-related bloodstream infection: prospective surveillance study.
Templeton A; Schlegel M; Fleisch F; Rettenmund G; Schöbi B; Henz S; Eich G
Infection; 2008 Aug; 36(4):322-7. PubMed ID: 18663408
[TBL] [Abstract][Full Text] [Related]
19. [Subcutaneous chamber systems (ports) for long-term care in cancer patients].
Hájek R; Sevcík P; Ondrásek J; Mayer J; Vásová I; Král Z; Tomíska M; Krahulcová E; Penka M; Kubesová H
Vnitr Lek; 1995 Jan; 41(1):21-7. PubMed ID: 7716888
[TBL] [Abstract][Full Text] [Related]
20. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.
Adler A; Yaniv I; Steinberg R; Solter E; Samra Z; Stein J; Levy I
J Hosp Infect; 2006 Mar; 62(3):358-65. PubMed ID: 16377030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
